SERPINB3 and cancer: This is due to the direct interaction between TMEM44‐AS1 and SerpinB3, which facilitates the binding of SerpinB3 to downstream targets, leading to the activation of the EGR1/IL‐6 signalling pathway and the subsequent promotion of cancer progression [48].